Information and calculation tools by Rachid Asen. Not investment advice or research.

Disclaimer. Information tool. Compiles data published by NSE and BSE and calculations from the exchanges' published ESM and ASM criteria. Prices are end-of-day, not live: updated each evening after trading ends. Ethical business criteria are matched by AI, which can make mistakes; this is a criteria match, not a certification, fatwa, rating or advice. Check the company's filings. Not investment advice, research or a recommendation to buy, sell or hold any security; not SEBI-registered as an Investment Adviser or Research Analyst. Calculated dates are the earliest a security could become eligible; inclusion, stage changes and exit are decided solely by the exchanges. ESM, ASM and GSM shortlisting are surveillance measures and not an adverse action against the company. Data may be delayed or inaccurate; verify with the exchange.

DIPNA PHARMACHEM LIMITED

DPL (BSE 543594) · ISIN INE0MC401013 · Pharmaceuticals · Est. 2011 · listed 2022 · website

Not on any surveillance list

Quarterly results

No quarterly results stored for this company yet.

Balance sheet

Balance sheet, ₹ crore (as filed)
As of	Total equity	Borrowings	Total assets
31 Mar 2026 standalone	₹62.3 cr	₹13.21 cr	₹205.63 cr
30 Sep 2025 standalone	₹58.89 cr	₹13.79 cr	₹177.48 cr
31 Mar 2025 standalone	₹38.49 cr	₹17.22 cr	₹132.38 cr

Latest filings

Submission of Financial Results 2 July 2026 · BSE
Outcome of Board Meeting held today i.e. 2nd July, 2026 2 July 2026 · BSE
Voting Results for Postal Ballot 25 May 2026 · BSE
Post Ballot - Scrutinizer''s Report 25 May 2026 · BSE
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Notice of Postal Ballot 22 April 2026 · BSE

Other companies in Pharmaceuticals

Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.

Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.